Health Care & Life Sciences » Biotechnology | Jinhe Biotechnology Co. Ltd.

Jinhe Biotechnology Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
275
229
225
265
345
492
Total Accounts Receivable
128
183
203
224
359
427
Inventories
125
301
310
300
337
366
Other Current Assets
52
54
63
76
40
31
Total Current Assets
581
766
802
865
1,080
1,316
Net Property, Plant & Equipment
410
489
565
695
805
896
Total Investments and Advances
-
-
225
3
4
5
Intangible Assets
30
263
289
1,071
1,044
1,078
Other Assets
-
-
1
20
21
36
Total Assets
1,022
1,520
1,885
2,662
2,960
3,335
ST Debt & Current Portion LT Debt
32
99
664
328
663
Accounts Payable
53
108
113
142
130
Income Tax Payable
7
4
5
12
15
Other Current Liabilities
14
16
31
48
47
Total Current Liabilities
105
228
812
529
855
Long-Term Debt
-
318
-
206
264
Deferred Taxes
1
2
2
101
71
Other Liabilities
-
-
-
204
94
Total Liabilities
105
546
812
1,047
1,290
Common Equity (Total)
901
951
1,035
1,496
1,527
Total Shareholders' Equity
901
951
1,035
1,496
1,527
Total Equity
900
956
1,055
1,584
1,637
Liabilities & Shareholders' Equity
1,022
1,520
1,885
2,662
2,960
Accumulated Minority Interest
1
6
19
88
111
Non-Equity Reserves
17
18
19
31
33

About Jinhe Biotechnology Co.

View Profile
Address
No. 71 Xinping Road
Hohhot Inner Mongolia 010200
China
Employees -
Website http://www.jinhe.com.cn
Updated 07/08/2019
Jinhe Biotechnology Co., Ltd. engages in the manufacture and sale of veterinary medicines. Its products include chlortetracycline feed grade, chlortetracycline hydrochloride, and salinomycin. The company was founded on March 14, 1990 and is headquartered in Hohhot, China.